Pain Control in Stroke

Introduction to Pain Management

The American College of Physicians recommends treating acute stroke pain symptomatically with standard analgesics while managing blood pressure, and using gabapentin or pregabalin as first-line therapy for post-stroke pain syndromes, followed by amitriptyline or duloxetine as second-line, reserving opioids for treatment-resistant cases 1

During the hyperacute and acute stroke period, pain should be addressed as part of blood pressure management, as pain itself can elevate blood pressure and complicate stroke care 2
The American Heart Association recommends treating headache, pain, agitation, nausea, and vomiting symptomatically in patients with systolic BP <220 or diastolic <120 mmHg who are not receiving thrombolytic therapy 2

The American College of Physicians recommends anticonvulsants (gabapentin or pregabalin) as first-line therapy for CPSP, which affects 2-8% of stroke patients and results from damage to the spinothalamic tract, causing hypersensitivity and sensory abnormalities 1
Gabapentin is effective for neuropathic pain conditions, though specific stroke data is limited 3
Pregabalin has mixed results for pain intensity but may improve sleep quality and anxiety, which are commonly impaired in stroke patients 3
Tricyclic antidepressants (amitriptyline 75mg at bedtime) or SNRIs (duloxetine) should be used as second-line options for CPSP 1, 3
Lamotrigine can reduce daily pain ratings and cold-induced pain, though only 44% of patients achieve good clinical response 1, 3

The American Academy of Physical Medicine and Rehabilitation recommends beginning with antispastic positioning, range of motion exercises, stretching, splinting, and serial casting as first-line treatments for spasticity-related pain 4, 1
Consider tizanidine, dantrolene, or oral baclofen for pharmacological management of spasticity causing pain, poor skin hygiene, or decreased function 4

An individualized patient-centered approach implemented by an interdisciplinary team with expertise in mental health and central pain management is essential for comprehensive pain management 1, 3
Pharmacotherapy must be combined with therapeutic exercise and psychosocial support 4, 1

CPSP is often underdiagnosed or misdiagnosed as musculoskeletal or visceral pain 1
Do not attribute all post-stroke pain to CPSP without excluding other serious causes 1
TENS (transcutaneous electrical nerve stimulation) is not effective for central post-stroke pain and should not be used 1, 3

Motor cortex stimulation might be reasonable for intractable central post-stroke pain not responsive to pharmacological treatments, achieving pain reductions >50% in 50-83% of patients for up to 2 years 1, 3